A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy

NCT06268613 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer Stage II
Non-small Cell Lung Cancer Stage IIIA

Interventions

DRUG: SB27
DRUG: EU sourced Keytruda
DRUG: US sourced Keytruda

Sponsor

Samsung Bioepis Co., Ltd.